PDCD1 and neoplasm: In addition, due to combining PD-1 inhibitors with platinum-based chemotherapy may enhance tumor immunogenicity [8], multiple ongoing clinical trials are evaluating the efficacy of combining PD-1 with platinum-based chemotherapy (such as gemcitabine/cisplatin [GC]) in NMIBC [9].